Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Alter Pharma group.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Alter Pharma group
CostaRica Flag
Country
Country
Costa Rica
Address
Address
Fuentecantos Building, front of Avenida Escazú
Telephone
Telephone
(506)-2288.6969
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Magnesium sulfate injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia. It reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction.


Lead Product(s): Magnesium Sulfate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Magnesium Sulfate-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Athenex

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 20, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Abbreviated New Drug Application (ANDA) for a generic version of Mestinon (Pyridostigmine Bromide Syrup) 60 mg/5mL, is indicated for symptomatic treatment of myasthenia gravis.


Lead Product(s): Pyridostigmine

Therapeutic Area: Immunology Product Name: Pyridostigmine Bromide-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Milla Pharmaceuticals

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 19, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Maxigesic IV (a unique combination of 1000 mg paracetamol and 300 mg ibuprofen solution for infusion) is a novel, patented, non-opioid pain treatment, and is being commercialised by Hyloris’ partner AFT Pharmaceuticals.


Lead Product(s): Paracetamol,Ibuprofen

Therapeutic Area: Neurology Product Name: Maxigesic IV

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Hyloris Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement June 24, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY